logo

For the Inventor, By the Inventor

Newbury Park, CA, United States of America

Rahul Rajan Kaushik

This inventor holds 5 USPTO granted patents and 9 published patent applications. Top assignee: Amgen Inc.. Active years: 2022-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rahul Rajan Kaushik. Retrieved from https://idiyas.com/inventor/rahul-rajan-kaushik

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5 

% Patents Active = 100.0

Average Co-Inventor Count = 4.9

ph-index = 1


Location History:

  • Thousand Oaks, CA (US) (2022)
  • Newbury Park, CA (US) (2022)

Company Filing History:

goldMedal5 out of 2,072 
 
Amgen Inc.
 patents

Years Active: 2022-2026

Loading Chart...
5 patents (USPTO):Explore Patents
1. 12679865 - Methods for making stable protein compositions (2026-07-14),
2. 12247071 - Anti-TNF alpha antibody formulations (2025-03-11),
3. 12156900 - VEGFR-Fc fusion protein formulations (2024-12-03),
4. 11459401 - Reduced viscosity protein pharmaceutical formulations (2022-10-04),
5. 11241502 - Stable compositions of pegylated carfilzomib compounds (2022-02-08),

Title: Innovations by Rahul Rajan Kaushik

Introduction

Rahul Rajan Kaushik is a prominent inventor based in Newbury Park, CA (US). He has made significant contributions to the field of biotechnology, particularly in the development of antibody formulations and fusion proteins. With a total of 5 patents to his name, Kaushik continues to push the boundaries of innovation in his field.

Latest Patents

Kaushik's latest patents include groundbreaking work on anti-TNF alpha antibody formulations. These stable adalimumab formulations are designed to improve therapeutic efficacy. Additionally, he has developed VEGFR-Fc fusion protein formulations, which provide methods for creating and utilizing such formulations. Notably, these formulations can be used as ophthalmic solutions, including for intravitreal administration, and may comprise a VEGFR-Fc fusion protein like aflibercept.

Career Highlights

Kaushik is currently employed at Amgen Inc., a leading biotechnology company known for its innovative therapies. His work at Amgen has allowed him to collaborate with other talented professionals in the industry, further enhancing his contributions to biotechnology.

Collaborations

Some of his notable coworkers include William Callahan and Alona Teran. Their collaborative efforts have played a crucial role in advancing the research and development of new therapeutic solutions.

Conclusion

Rahul Rajan Kaushik is a distinguished inventor whose work in biotechnology has led to significant advancements in antibody and protein formulations. His contributions continue to impact the field positively, showcasing the importance of innovation in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…